KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Gross Margin: 2013-2015

Historic Gross Margin for Biocryst Pharmaceuticals (BCRX) over the last 2 years, with Sep 2015 value amounting to 87.75%.

  • Biocryst Pharmaceuticals' Gross Margin was N/A to 87.75% in Q3 2015 from the same period last year, while for Sep 2015 it was 95.80%, marking a year-over-year change of. This contributed to the annual value of 99.11% for FY2014, which is 32.00% down from last year.
  • Biocryst Pharmaceuticals' Gross Margin amounted to 87.75% in Q3 2015, which was down 10.43% from 97.97% recorded in Q2 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Gross Margin ranged from a high of 99.84% in Q4 2013 and a low of 87.75% during Q3 2015.
  • Its 3-year average for Gross Margin is 96.51%, with a median of 98.55% in 2015.
  • Per our database at Business Quant, Biocryst Pharmaceuticals' Gross Margin soared by 904bps in 2014 and then crashed by 169bps in 2015.
  • Biocryst Pharmaceuticals' Gross Margin (Quarterly) stood at 99.84% in 2013, then plummeted by 63bps to 99.21% in 2014, then slumped by 169bps to 87.75% in 2015.
  • Its Gross Margin stands at 87.75% for Q3 2015, versus 97.97% for Q2 2015 and 99.12% for Q1 2015.